Biovica International AB (publ) (BIOVIC-B) - Cash Flow Conversion Efficiency

Latest as of July 2025: -0.670x

Based on the latest financial reports, Biovica International AB (publ) (BIOVIC-B) has a cash flow conversion efficiency ratio of -0.670x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.20 Million ≈ $-1.85 Million USD) by net assets (Skr25.68 Million ≈ $2.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIOVIC-B equity to assets ratio to measure how much of total assets are equity-financed.

Biovica International AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Biovica International AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BIOVIC-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Biovica International AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biovica International AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korea Mcnulty Co Ltd KQ:222980	0.053x
Dhunseri Tea & Industries Limited NSE:DTIL	0.040x
WiMi Hologram Cloud Inc NASDAQ:WIMI	0.044x
Moment Group AB ST:MOMENT	-0.613x
Relpol SA WAR:RLP	0.030x
Northeast Electric Development Company Limited F:NE4H	0.009x
Office Properties Income Trust NASDAQ:OPI	0.030x
Lachlan Star Ltd AU:LSA	-0.026x

Annual Cash Flow Conversion Efficiency for Biovica International AB (publ) (2015–2025)

The table below shows the annual cash flow conversion efficiency of Biovica International AB (publ) from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Biovica International AB (publ).

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-04-30	Skr43.21 Million ≈ $4.65 Million	Skr-85.37 Million ≈ $-9.19 Million	-1.976x	-66.65%
2024-04-30	Skr96.64 Million ≈ $10.40 Million	Skr-114.58 Million ≈ $-12.33 Million	-1.186x	-73.67%
2023-04-30	Skr138.64 Million ≈ $14.92 Million	Skr-94.64 Million ≈ $-10.18 Million	-0.683x	-62.51%
2022-04-30	Skr124.09 Million ≈ $13.35 Million	Skr-52.13 Million ≈ $-5.61 Million	-0.420x	-123.00%
2021-04-30	Skr182.66 Million ≈ $19.66 Million	Skr-34.41 Million ≈ $-3.70 Million	-0.188x	+40.54%
2020-04-30	Skr78.22 Million ≈ $8.42 Million	Skr-24.78 Million ≈ $-2.67 Million	-0.317x	+8.13%
2019-04-30	Skr52.10 Million ≈ $5.61 Million	Skr-17.97 Million ≈ $-1.93 Million	-0.345x	-70.81%
2018-04-30	Skr73.71 Million ≈ $7.93 Million	Skr-14.88 Million ≈ $-1.60 Million	-0.202x	-66.66%
2017-04-30	Skr91.55 Million ≈ $9.85 Million	Skr-11.09 Million ≈ $-1.19 Million	-0.121x	+67.11%
2016-04-30	Skr25.48 Million ≈ $2.74 Million	Skr-9.38 Million ≈ $-1.01 Million	-0.368x	-432.23%
2015-04-30	Skr8.32 Million ≈ $894.93K	Skr922.00K ≈ $99.22K	0.111x	--

About Biovica International AB (publ)

ST:BIOVIC-B Sweden Biotechnology

Market Cap

$14.81 Million

Skr137.64 Million SEK

Market Cap Rank

#25994 Global

#542 in Sweden

Share Price

Skr0.50

Change (1 day)

+0.00%

52-Week Range

Skr0.28 - Skr0.69

All Time High

Skr66.10